In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab-Reference-Cited by-同舟云学术

In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab

Published:2019-10-12 Issue:1 Volume:146 Page:236-247
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Caratelli Sara¹,Arriga Roberto²,Sconocchia Tommaso³,Ottaviani Alessio¹,Lanzilli Giulia¹,Pastore Donatella²,Cenciarelli Carlo¹,Venditti Adriano⁴,Del Principe Maria Ilaria⁴,Lauro Davide²,Landoni Elisa⁵,Du Hongwei⁵,Savoldo Barbara⁵,Ferrone Soldano⁶,Dotti Gianpietro⁵,Sconocchia Giuseppe¹^ORCID

Affiliation:

1. Department of Biomedical SciencesInstitute of Translational Pharmacology, CNR Rome Italy

2. Department of Systems MedicineUniversity of Rome “Tor Vergata” Rome Italy

3. Otto Loewi Research Center, Chair of Immunology and PathophysiologyMedical University of Graz Graz Austria

4. Hematology, Department of Biomedicine and PreventionUniversity of Rome “Tor Vergata” Rome Italy

5. Lineberger Comprehensive Cancer CenterUniversity of North Carolina Chapel Hill NC

6. Department of SurgeryMassachusetts General Hospital, Harvard Medical School Boston MA

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32663

Reference29 articles.

1. Fcγ receptors as regulators of immune responses

2. Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses

3. EGFR Targeting of Solid Tumors

4. Human IgG2 Antibodies against Epidermal Growth Factor Receptor Effectively Trigger Antibody-Dependent Cellular Cytotoxicity but, in Contrast to IgG1, Only by Cells of Myeloid Lineage

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies;Frontiers in Immunology;2024-04-12

2. Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review;Sensors;2023-12-15

3. Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”;International Journal of Molecular Sciences;2023-12-10

4. Journey of CAR T‑cells: Emphasising the concepts and advancements in breast cancer (Review);International Journal of Oncology;2023-10-10

5. Breast cancer immunotherapy: a comprehensive review;Clinical and Experimental Medicine;2023-09-01